Showing 553 - 564 of 1886
China’s bond sale in Riyadh this week caps a year marked by accelerating Gulf investments on the mainland.
The academic and author discusses the state of China's space industry, where its rivalry with the U.S. could play out and how any escalation could...
Have foreign firms reached the tipping point on China?
Foreign companies face a reckoning in China as the risks of staying are generating diminishing returns.
Beijing’s efforts to stabilize its faltering economy have been too weak to date. The situation is likely to worsen following Donald Trump’s election win.
Beijing is taking lessons from the U.S. as it attempts to get more international companies to comply with its sanctions.
Innovative Chinese companies still want to list in the U.S., even those with little chance of ever operating there.
The British author relates the truth behind Wallis Simpson's time in Shanghai, her activities for U.S. intelligence and the plight of the modern China book.
China has played far more of a supporting role this year than in other recent presidential campaigns.
Foreign pharmaceutical firms are eyeing the world’s second largest market for profit opportunities as well as innovative assets.
The current political climate in the U.S. is harming its relations with China.
Untangling the alleged TSMC-Sophgo-Bitmain-Huawei chain.